Evidence that in vitro susceptibility of CD3+ T lymphocytes to equine arteritis virus infection reflects genetic predisposition of naturally infected stallions to become carriers of the virus.

The study examines the relationship between the natural vulnerability of certain white blood cells (CD3(+) T lymphocytes) to equine arteritis virus (EAV) infection and the likelihood of horses developing a persistent infection after initial exposure to the virus.

Research Objective

• The study aimed to explore the connection between the in vitro (in a controlled environment outside a living organism) susceptibility of certain white blood cells (CD3(+) T lymphocytes) to equine arteritis virus (EAV) infection and the predisposition of horses to develop a long-term infection following natural exposure to the virus.

Methodology

• To achieve the objective, the researchers investigated 14 naturally infected stallions (male horses). The natural infections in these stallions served as actual biological settings for the study.

Results

• The research showed that stallions whose CD3(+) T lymphocytes exhibited susceptibility to EAV infection in vitro were more likely to become carriers of the virus. In other words, these stallions developed a persistent infection rather than completely recovering after initial exposure.
• The study findings showed a significant association (P=0.0002, signifying a very low probability that the results happened by chance) between the CD3(+) T lymphocyte susceptibility phenotype and the potential for a stallion to become a carrier of EAV. A ‘phenotype’ is the set of observable characteristics or traits resulting from the interaction of its genotype (set of genes) with the environment.
• Stallions that did not display this phenotype (i.e., their CD3(+) T lymphocytes did not show in vitro vulnerability to EAV) were at a lower risk of becoming carriers.

Significance

• The research findings could have important implications for understanding why some horses become carriers of EAV—a condition that can have serious health consequences for the horse population—while others can resist the virus.
• If this genetic predisposition to becoming virus carriers can be identified through testing, it could potentially lead to preventive measures or treatments to control the spread of EAV within the horse population.